Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 22706011)

1.

The design and evaluation of HIV-1 vaccines.

Saunders KO, Rudicell RS, Nabel GJ.

AIDS. 2012 Jun 19;26(10):1293-302. doi: 10.1097/QAD.0b013e32835474d2. Review.

PMID:
22706011
2.

No acquisition: a new ambition for HIV vaccine development?

Lakhashe SK, Silvestri G, Ruprecht RM.

Curr Opin Virol. 2011 Oct;1(4):246-53. doi: 10.1016/j.coviro.2011.07.005. Review.

3.

HIV vaccine efficacy trials: towards the future of HIV prevention.

Kim D, Elizaga M, Duerr A.

Infect Dis Clin North Am. 2007 Mar;21(1):201-17, x.

PMID:
17502236
4.

Human immunodeficiency virus vaccines.

Goepfert P, Bansal A.

Infect Dis Clin North Am. 2014 Dec;28(4):615-31. doi: 10.1016/j.idc.2014.08.004. Epub 2014 Oct 5. Review.

5.

The HIV vaccine pipeline, from preclinical to phase III.

Schultz AM, Bradac JA.

AIDS. 2001;15 Suppl 5:S147-58. Review. No abstract available.

PMID:
11816163
6.

Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.

Kwong PD, Mascola JR, Nabel GJ.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007278. doi: 10.1101/cshperspect.a007278. Review.

7.

HIV vaccines: progress to date.

Munier CM, Andersen CR, Kelleher AD.

Drugs. 2011 Mar 5;71(4):387-414. doi: 10.2165/11585400-000000000-00000. Review.

PMID:
21395355
8.

Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.

Rolland M, Gilbert P.

AIDS Res Hum Retroviruses. 2012 Apr;28(4):400-4. doi: 10.1089/AID.2011.0240. Epub 2011 Sep 27.

9.

HIV-1 vaccines and adaptive trial designs.

Corey L, Nabel GJ, Dieffenbach C, Gilbert P, Haynes BF, Johnston M, Kublin J, Lane HC, Pantaleo G, Picker LJ, Fauci AS.

Sci Transl Med. 2011 Apr 20;3(79):79ps13. doi: 10.1126/scitranslmed.3001863.

10.

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning.

Kwong PD, Mascola JR, Nabel GJ.

Nat Rev Immunol. 2013 Sep;13(9):693-701. doi: 10.1038/nri3516.

PMID:
23969737
11.

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

Girard MP, Osmanov S, Assossou OM, Kieny MP.

Vaccine. 2011 Aug 26;29(37):6191-218. doi: 10.1016/j.vaccine.2011.06.085. Epub 2011 Jun 28. Review.

PMID:
21718747
12.

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA.

Science. 2004 Jan 16;303(5656):316. No abstract available.

PMID:
14726576
13.

A global approach to HIV-1 vaccine development.

Stephenson KE, Barouch DH.

Immunol Rev. 2013 Jul;254(1):295-304. doi: 10.1111/imr.12073. Review.

14.

International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China.

Li D, Forrest BD, Li Z, Xue P, Hanson CV, Duan S, Cheng H, Li M, Wang CY, Koff WC.

Asian Pac J Allergy Immunol. 1997 Jun;15(2):105-13.

PMID:
9346275
15.

Controversial HIV vaccine enters phase III trials amid skepticism.

[No authors listed]

AIDS Alert. 1998 Dec;13(12):133-4, 136.

PMID:
11366059
16.

HIV vaccines in infants and children.

Lambert JS.

Paediatr Drugs. 2005;7(5):267-76. Review.

PMID:
16220994
17.

What hope is there for an HIV vaccine?

Witten G.

S Afr Med J. 2004 Oct;94(10):831. No abstract available.

18.

Tiny steps towards an HIV vaccine.

Willyard C.

Nature. 2010 Jul 15;466(7304):S8. doi: 10.1038/nature09238. No abstract available.

PMID:
20631706
19.

Support for the RV144 HIV vaccine trial.

AIDS Vaccine Advocacy Coalition.

Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. No abstract available.

PMID:
15250069
20.

Update on HIV vaccines.

Meldorf M, Corey L.

STEP Perspect. 1997 Summer;9(2):5-6, 8-9.

PMID:
11364929
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk